Rab38 and Rab32 control post-Golgi trafficking of melanogenic enzymes. by Wasmeier, C et al.
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
IO
L
O
G
Y
JCB: ARTICLE
© The Rockefeller University Press  $8.00
The Journal of Cell Biology, Vol. 175, No. 2, October 23, 2006 271–281
http://www.jcb.org/cgi/doi/10.1083/jcb.200606050 JCB 271
Introduction
Melanocytes are specialized pigment-producing cells residing 
in the skin and eyes of mammals. Melanin is synthesized and 
stored in melanosomes, membrane-bound subcellular organelles. 
These share some characteristics with lysosomes, but also pos-
sess several melanosome-specifi c components, including ma-
trix proteins and melanin-synthesizing enzymes. Melanosome 
biogenesis can be divided into four morphologically distinct 
stages. Stage I premelanosomes are nonpigmented vacuoles de-
rived from endosomes, which then acquire internal striations 
(stage II). Melanin formation results in pigment being deposited 
onto these striations, giving rise to stage III, and eventually fully 
melanized electron-dense stage IV melanosomes. The highly 
dendritic architecture of melanocytes in the skin allows transfer 
of mature pigment granules to a large number of keratinocytes, 
resulting in normal pigmentation (Marks and Seabra, 2001; 
 Raposo and Marks, 2002; Hearing, 2005).
The study of mouse mutants displaying alterations in coat 
color has identifi ed a large number of gene products that affect 
pigmentation (Bennett and Lamoreux, 2003). Many of these are 
involved in melanosome function. They include the enzymes 
 required for melanin synthesis, primarily tyrosinase, as well as 
tyrosinase-related protein (Tyrp/TRP) 1 and Dct (TRP2; Hearing, 
2005), and molecules with structural roles in melanosome for-
mation, such as Pmel17 (Theos et al., 2005b). Others are involved 
in the regulation of intracellular protein traffi cking and or-
ganelle biogenesis. Most mouse models for Hermansky-Pudlak 
syndrome (HPS), a heterogeneous group of disorders associated 
with albinism in humans, fall into this category. They include 
subunits of the biogenesis of lysosome-related organelles com-
plexes (BLOCs), of adaptor protein 3 (AP-3), or of the homotypic 
vacuolar protein sorting complex (Li et al., 2004; Pietro and 
Dell’Angelica, 2005; Wei, 2006). Others again are required for cor-
rect intracellular distribution of melanosomes, for example, Rab27a, 
melanophilin, and myosinVa (Seabra and Coudrier, 2004).
Analysis of the coat color mutant “chocolate” (cht) identi-
fi ed the small GTPase Rab38 as another gene involved in the 
regulation of pigmentation (Loftus et al., 2002). The Rab family 
of proteins consists of >60 members in mammalian cells 
(Pereira-Leal and Seabra, 2001). Some are ubiquitously ex-
pressed, whereas others are highly tissue specifi c, refl ecting 
more specialized roles. Each Rab protein shows a characteristic 
subcellular distribution and may thus represent an important de-
terminant of organelle identity (Pfeffer, 2001; Munro, 2002; Seabra 
and Wasmeier, 2004). Rabs serve as key regulators of vesicular 
traffi cking between subcellular compartments. They have been 
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implicated in the formation of vesicles at the donor membrane 
and in the tethering, docking, and fusion of vesicles or organ-
elles with their target membranes (Segev, 2001; Zerial and 
 McBride, 2001). They are also involved in a variety of other 
processes, for example, the regulation of early endosome motility 
by Rab5 (Nielsen et al., 1999), the capture of melanosomes at 
Figure 1. Pigmentation in melanocytes 
 car rying the cht mutation and biochemical 
 characterization of cht mutant Rab38G19V. 
(A) Brightﬁ eld images of control +/cht and 
 homozygous cht/cht primary skin melanocytes 
at 1–5 wk in culture. (B) Primary melanocytes 
cultured for 5 wk were processed for con-
ventional EM. Sections show cytoplasmic or-
ganelles near the cell periphery. Bar, 500 nm. 
(C) Brightﬁ eld images of immortal melanocyte 
cell lines derived from BL/6 (melan-Ink4a) or 
cht (melan-cht) mice carrying an Ink4a deletion. 
(D) BL/6 or cht melanocyte homogenates were 
separated into soluble (S) and pelletable 
(P) fractions by centrifugation at 100,000 g 
(100K) or into aqueous (A) and detergent 
(D) fractions by extraction with Triton X-114 
(TX-114). The distribution of Rab38, or Rab27a 
as a control, was analyzed by immunoblotting. 
(E) BL/6 cells were transiently transfected 
with EGFP-Rab38 or -Rab38G19V, as indicated. 
EGFP ﬂ uorescence and the corresponding 
phase-contrast images are shown. (right) 
Boxed regions at higher magniﬁ cation, with 
pigment represented by an inverted phase-
 contrast image.
Figure 2. Expression pattern and subcellular 
localization of Rab38 and Rab32. (A) Proteins 
from BL/6 or cht melanocytes were separated 
by SDS-PAGE and immunoblotted for Rab38, 
Rab32, and α-tubulin (α-tub) as loading control. 
(B) Melanocytes were transiently cotrans-
fected with EGFP-Rab32 and mRFP-Rab38. 
Green and red ﬂ uorescent signals are shown, 
and colocalization is represented in yellow in 
the merged images. (bottom) A cell process at 
higher magniﬁ cation. (C) Proteins from mouse 
tissues (50 μg/lane) or from a range of cul-
tured mouse or rat cell lines available in our 
laboratory (25 μg/lane) were separated by 
SDS-PAGE and immunoblotted for Rab38, 
Rab32, and tubulin as loading control. (right 
and left) α-Tubulin; (middle) γ-tubulin. The 
asterisk indicates a nonspeciﬁ c band in the 
Rab32 panels.
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the cell periphery by Rab27a (Seabra and Coudrier, 2004), or 
the remodeling of the cytoskeleton by Rab8 (Peranen et al., 
1996). The regulatory capacity of Rab proteins is based on their 
ability to act as GTP-dependent molecular switches, with acti-
vation coupled to reversible association with intracellular 
 membranes. In this way, Rabs can control the recruitment of 
downstream effectors to specifi c subcellular compartments in 
an activation-dependent way (Seabra and Wasmeier, 2004).
Rab38 is predominantly expressed in melanocytes and 
retinal pigment epithelial cells and is localized to pigmented 
melanosomes. In the cht mouse, a recessive Gly19 to Val point 
mutation was identifi ed in Rab38. The resulting coat color phe-
notype resembles that of the brown mouse, which carries a mu-
tation in Tyrp1, and reduced levels of Tyrp1 were reported in 
melanosomes of cultured cht melanocytes, suggesting an in-
volvement of Rab38 in Tyrp1 transport (Loftus et al., 2002). 
The present study characterizes Rab38 in the cht mutant and 
defi nes a role for Rab38 in melanosome biogenesis. We demon-
strate that Rab38 and the closely related Rab32 are important, 
functionally redundant regulators of melanosomal protein traf-
fi cking and melanocyte pigmentation.
Results
Pigmentation in cht mutant melanocytes
Primary skin melanocytes isolated from homozygous cht/cht 
mice showed strikingly reduced levels of pigmentation com-
pared with cells from +/cht littermate controls when observed 
during the initial 2–3 wks in culture. After prolonged culture 
of 4 or 5 wks, however, cht/cht melanocytes appeared similar to 
+/cht controls (Fig. 1 A). Ultrastructural analysis of these cells 
showed no major differences between cht/cht and +/cht in the 
extent of melanization or melanosome size (Fig. 1 B). Immortal 
melanocyte cell lines derived from cht/cht mice (melan-cht) are 
also well pigmented (Fig. 1 C).
Characterization of cht Rab38
Because the cht phenotype results from a single amino acid 
change in Rab38, the presence of substantial numbers of mature 
pigment granules in cht/cht melanocytes could be due to the 
mutant protein (Rab38G19V) retaining some functional activity. 
Rabs are peripheral membrane proteins that rely on geranyl-
geranylation for association with cellular membranes and func-
tion (Seabra and Coudrier, 2004). We therefore analyzed the 
expression and subcellular localization of Rab38 in control 
BL/6-derived melan-Ink4a melanocytes (BL/6) and in melan-
cht melanocytes (cht) by subcellular fractionation (Fig. 1 D). In 
BL/6 cells, the majority of Rab38 was pelleted by centrifuga-
tion at 100,000 g, demonstrating association with cellular mem-
branes, and partitioned into the detergent phase upon extraction 
with Triton X-114, indicating lipid modifi cation. In cht cells, 
the total levels of Rab38 were substantially reduced. More im-
portant, the protein was exclusively detected in the cytosolic 
fraction or in the aqueous phase. A control Rab, Rab27a, was 
pelleted and detergent extracted equally in both cell lines. 
 Recombinant EGFP-tagged Rab38 expressed in BL/6 melano-
cytes showed a characteristic punctate pattern. It localized 
 primarily to perinuclear membranes but also to the cell peri-
phery, where it was frequently observed overlapping with or in 
close proximity to pigmented melanosomes (Fig. 1 E; and see 
Figs. 4, 5, and 6). EGFP-Rab38G19V was diffusely distributed 
throughout the cytoplasm, with a concentration in the nucleus 
that is characteristic of soluble EGFP-tagged Rab mutants. 
These results suggest that cht mutant Rab38 is unstable, lacks 
posttranslational lipid modifi cation, and does not associate with 
cellular membranes, rendering it functionally inactive.
Rab38 and Rab32 can functionally 
compensate for each other 
in pigment biosynthesis
A lower rate of pigment synthesis in cht melanocytes may 
 implicate Rab38 in fi ne-tuning the kinetics of this pathway. 
Figure 3. Rab38 and Rab32 are required for melanocyte pigmentation 
and act in a functionally redundant way. (A) EGFP (E) or EGFP-Rab38 
(E-38) were stably overexpressed in cht cells using lentiviral vectors. Cellular 
proteins were immunoblotted for EGFP or Rab38, as indicated. Melanin con-
tent was assayed by measuring optical density at 492 nm (OD492). Assays 
were performed in triplicate; means and standard deviations are depicted. 
(B) Cht cells were transfected with either control siRNA oligos or Rab32-
 speciﬁ c siRNA oligos (32-1 or 32-2). Cellular proteins were immuno blotted for 
Rab32 and α-tubulin. (C) Cht cells expressing EGFP (cht:E) or EGFP-Rab38 
(cht:E-38) were subjected to two rounds of transfection with control or Rab32-
speciﬁ c siRNA oligos. Melanin content was measured on day 10 after the ini-
tial transfection. Assays were performed in triplicate, as above. Cells were 
also analyzed for expression of Rab32 by immuno blotting (bottom).
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However, it is also possible that Rab38 regulates a more funda-
mental step in melanosome biogenesis, but that alternative 
mechanisms can at least partially compensate for the loss of 
Rab38 function in cht. Rab38 is closely related to Rab32, an-
other member of the Rab family (Jager et al., 2000; Bao et al., 
2002; Cohen-Solal et al., 2003). The mouse Rab38 and Rab32 
proteins are 67% identical. This is more comparable to the de-
gree of sequence identity between Rab isoforms such as Rab27a 
and -27b (72%), Rab3a and -3b (78%), or Rab5a and -5b (82%), 
which are able to functionally compensate for each other, than 
to that between more distantly related Rabs, which are typically 
only between 20 and 30% identical. To determine whether there 
could potentially be redundancy between Rab38 and Rab32, we 
examined the expression and subcellular localization of Rab32 
in melanocytes. Cht cells expressed similar levels of Rab32 to 
control BL/6 cells (Fig. 2 A). In melanocytes cotransfected with 
EGFP-tagged Rab38 and mRFP-tagged Rab32, almost com-
plete colocalization was observed, with both Rabs being tar-
geted to the same vesicular structures at the cell periphery, as 
well as within the cell body (Fig. 2 B). 
In addition to melanocytes, Rab38 was expressed in bone 
marrow mast cells and basophil-derived RBL cells and at lower 
levels in lung and lung alveolar type II–derived MLE-12 cells 
(Fig. 2 C). It was not detected in liver, brain, spleen, or kidney, 
or in bone marrow dendritic cells, RAW (macrophage), AR42J 
(exocrine pancreas), MIN6 and INS-1 (insulinoma), or AtT20 
(anterior pituitary) cells. Low levels of Rab32 were observed in 
liver, lung, and kidney, which may indicate its presence in a 
subpopulation of cells within these tissues. Rab32 was also seen 
in spleen, bone marrow mast cells, bone marrow dendritic cells, 
and macrophage-derived RAW cells. Other cell types tested 
were negative (Fig. 2 C), suggesting a highly tissue-specifi c ex-
pression pattern for both Rab38 and Rab32. 
As shown in Fig. 1 C, cht melanocytes possess substantial 
levels of pigment. Recombinant EGFP-tagged Rab38 was over-
expressed in these cells (cht:EGFP-Rab38) using lentiviral 
 vectors. This resulted in a small but reproducible increase in 
melanin content relative to noninfected (not depicted) or EGFP-
expressing cht cells (cht:EGFP; Fig. 3 A), indicating that Rab38 
activity is indeed able to stimulate pigment biosynthesis. 
We then used Rab32-specifi c siRNA oligonucleotides to 
investigate the potential contribution of Rab32 to pigment 
 biogenesis. Transfection with four different siRNAs (including 
32–1 and 32–2, and others not depicted) resulted in a substantial 
reduction in Rab32 protein levels, whereas control oligonucle-
otides showed no effect (Fig. 3 B). Rab32 siRNA–transfected 
cht cells, but not cells treated with control siRNA, gradually lost 
pigmentation. Pigment was measured in cht:EGFP cells 10 d 
after the fi rst of two rounds of transfection. A 70 or 87% de-
crease in melanin content, respectively, was observed in cells 
treated with oligos 32-1 and 32-2 (Fig. 3 C). In contrast, in cht:
EGFP-Rab38 cells, where Rab38 function was restored by sta-
bly expressing exogenous Rab38, a knock down of Rab32 had 
no effect on melanin levels (Fig. 3 C). This suggests a role for 
Rab32 in regulating pigment biogenesis and demonstrates that 
Rab38 and Rab32 can functionally compensate for each other, 
Figure 4. Rab38 colocalizes with melano-
somal proteins in peripheral melanosomes and 
in perinuclear vesicles. BL/6 melanocytes were 
transiently transfected with EGFP-Rab38 (EGFP-
38; A and F). Cells were ﬁ xed, permeabilized, 
and labeled with antibodies to tyrosinase (B) 
or Tyrp1 (G), as indicated. (C and H) Merged 
ﬂ uorescent images; (D and I) corresponding 
phase-contrast images; (E and J) Fluorescent 
signals and phase contrast (blue) are merged. 
Panels show regions of cells that include peri-
nuclear and peripheral areas, and insets rep-
resent the whole cell. (K–O) Labeled structures 
at the cell periphery are depicted at higher 
magniﬁ cation; EGFP-Rab38 (K), pigment (L), 
Tyrp1 (N), and merged images (M and O) are 
shown. (P–W) Melanocytes were cotransfected 
with EGFP-Rab27a (P and T) and mRFP-Rab38 
(Q and U). (R and V) Merged images; (S and 
W) phase contrast.
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whereas the loss of both Rab proteins leads to a dramatic reduc-
tion in melanocyte pigmentation. 
Subcellular localization of Rab38 and Rab32
Pigment generation requires the formation of an immature me-
lanosome and its subsequent maturation. To analyze further 
how Rab38 and Rab32 may contribute to this complex process, 
the subcellular localization of these Rab proteins was examined 
in more detail. EGFP-tagged Rab38 (and EGFP-Rab32; Fig. 2 B 
and not depicted) displays a characteristic distribution in 
 melanocytes, where it is present at the cell periphery and on 
a population of vesicular structures in the perinuclear region 
(Fig. 4). A similar pattern was observed for endogenous Rab38 
(Fig. 5). Labeling of EGFP-Rab38–expressing cells with anti-
bodies to tyrosinase or Tyrp1 showed extensive colocalization 
with both melanosome markers (Fig. 4). At the cell periphery, 
EGFP-Rab38 partially colocalized with mature pigmented 
 melanosomes. More frequently, however, Rab38-positive vesi-
cles contained tyrosinase or Tyrp1 but were devoid of pigment, 
especially in the perinuclear region (Fig. 4, A–O). The distri-
bution of Rab38 overlapped with that of Rab27a, another mela-
nosome marker, but with Rab38 more prominent on perinuclear 
membranes and Rab27a more concentrated on peripheral, 
 pigmented melanosomes (Fig. 4, P–W). 
To determine if nonpigmented Rab38-positive structures 
could represent newly synthesized, immature melanosomes, we 
used MNT-1 human melanoma cells, a particularly good model 
for analyzing early-stage organelles because of their relative 
abundance (Raposo et al., 2001). Again, Rab38 colocalized ex-
tensively with Tyrp1, both in the cell periphery and in the peri-
nuclear region (Fig. 5). MNT-1 cells were also double labeled 
for Rab38 and the melanosomal matrix protein Pmel17 (Fig. 5). 
Antibody HMB45 is specifi c for a maturation-dependent cleav-
age form of Pmel17 and selectively labels stage II (striated but 
nonpigmented) melanosomes (Raposo et al., 2001). Little co-
localization was observed between Rab38 and Pmel17 by immuno-
fl uorescence (IF) microscopy. Immunogold EM on cells stably 
expressing EGFP-tagged Rab38 did not detect Rab38 on stage II 
melanosomes either (Fig. 5 H). Instead, in addition to mature 
pigmented (stage IV) melanosomes, EGFP-Rab38 was present 
on small cytoplasmic vesicles and tubules, frequently seen near 
the Golgi apparatus or in close proximity to melanosomes 
(Fig. 6 A). Many of these vesicular structures also contained 
Tyrp1. Similarly, EGFP-Rab38 was observed on Tyrp1-positive 
(not depicted) and on tyrosinase-positive cytoplasmic vesicles 
in BL/6-derived mouse melanocytes (Fig. 6 B). We detected 
 little colocalization between Rab38 or Rab32 and markers for 
the Golgi, the TGN, or the early endosome (unpublished data). 
Collectively, its subcellular localization suggests a possible role 
for Rab38 in regulating a vesicular transport step involved in 
the delivery of both Tyrp1 and tyrosinase from the TGN to the 
maturing melanosome.
Trafﬁ cking of tyrosinase and Tyrp1 
is disrupted in Rab38/Rab32-deﬁ cient cells
Melanocytes lacking functional Rab38 and Rab32, i.e., cht cells 
treated with Rab32-specifi c siRNAs (Rab38/Rab32-defi cient cells), 
are characterized by a drastic reduction in the number of pigmented 
melanosomes. The abundance and distribution of Pmel17-positive 
vesicles, however, resembled that in control cells, as assessed by 
IF microscopy of HMB45-labeled cells (Fig. 7 A). Ultrastructural 
analysis confi rmed that nonpigmented stage II melanosomes were 
still being formed (Fig. 7, B and C).
In control cht cells, Tyrp1 and tyrosinase localized to ves-
icles distributed throughout the cytoplasm and along the cell 
periphery, with an additional pool in the Golgi region. In con-
trast, in Rab38/Rab32-defi cient cells, Tyrp1 and tyrosinase were 
almost exclusively restricted to the perinuclear region (Fig. 8). 
Little Tyrp1, and virtually no tyrosinase, was detected on 
 peripheral structures in these cells. This change in subcellular 
distribution suggests that the loss of pigmentation induced by 
Rab32 knockdown is the result of a disruption in the  intracellular 
traffi cking of Tyrp1 and, more important, tyrosinase.
The perinuclear pool of tyrosinase in control cht cells 
as well as tyrosinase in Rab38/Rab32-defi cient cells showed a 
high degree of colocalization with TGN38, a marker for the 
TGN (Fig. 9). Post-Golgi sorting of tyrosinase is thought to in-
volve traffi cking through an endosomal compartment (Theos 
et al., 2005a). In Rab38/Rab32-defi cient cells, some additional 
tyrosinase-positive structures were frequently observed in close 
Figure 5. Rab38-positive structures are distinct from stage II  melanosomes. 
MNT-1 cells were ﬁ xed, permeabilized, and double labeled with antibodies 
to Rab38 (A and D) and either Tyrp1 (B and C) or Pmel17 (HMB45; E–G). 
(C, F, and G) Merged images; (A’–C’ and G) higher magniﬁ cations. 
(H) MNT-1 cells were transduced with lentivirus to stably express EGFP-Rab38 
and were processed for immuno-EM. Ultrathin cryosections were double 
 labeled with antibodies to EGFP (10-nm gold) and Pmel17 (5-nm gold). 
Stage II and IV melanosomes (arrows) are indicated.
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proximity to the TGN38-labeled compartment. However, these 
did not appear to possess either AP-3 or the transferrin receptor 
(unpublished data); thus, it is not clear if they could represent 
such endosomes.
To distinguish between newly synthesized protein in tran-
sit through the Golgi stack and protein retained in this compart-
ment because of a block in transport, protein synthesis was 
inhibited with cycloheximide for 3 h. In control cells, this re-
sulted in depletion of the perinuclear pool of tyrosinase, whereas 
protein in peripheral melanosomes was not affected, and no 
substantial changes in overall levels of tyrosinase were ob-
served. In contrast, the majority of Rab38/Rab32-defi cient cells 
(70% of depigmented cells compared with <10% of control 
cells) showed drastically reduced tyrosinase labeling after incu-
bation with cycloheximide (Fig. 9), indicating degradation of 
the protein after its exit from the TGN. Any residual tyrosinase 
seen in these cells remained largely colocalized with TGN38, 
with no obvious accumulation in a post-TGN compartment. 
This argues for a critical Rab38/Rab32-dependent step in the 
traffi cking of tyrosinase from the TGN to the melanosome.
Cht cells were transfected with Rab32 siRNA to induce 
loss of pigmentation and were subsequently infected with virus 
introducing either EGFP or EGFP-Rab38. Expression of EGFP 
alone did not affect levels of pigmentation or the characteristic 
perinuclear localization of tyrosinase. In contrast, in cells ex-
pressing EGFP-Rab38, traffi cking of tyrosinase to cytoplasmic 
and peripheral vesicles was restored, concomitant with the cells 
recovering normal levels of pigmentation (Fig. 10 A). Approxi-
mately 59% of EGFP-expressing cells in this experiment were 
depigmented and showed restriction of tyrosinase to the TGN 
region, whereas only 10% of EGFP-Rab38–positive cells had 
not recovered both pigmentation and a normal subcellular dis-
tribution of tyrosinase (Fig. 10 B). This further supports the 
conclusion that Rab38 can rescue melanosome biogenesis in 
Rab38/Rab32-defi cient cells and that it restores pigment bio-
synthesis by mediating tyrosinase transport from a perinuclear 
compartment to the melanosome.
Discussion
We show here for the fi rst time that Rab38 and Rab32 act in 
a functionally redundant way in regulating skin melanocyte 
pigmentation. These Rab proteins control an important post-Golgi 
step in the traffi cking of key melanogenic enzymes and are 
therefore critical for melanosome maturation.
The identifi cation of the cht mutation as Rab38G19V impli-
cated Rab38 in the regulation of pigment biogenesis (Loftus 
et al., 2002), but the effect of this mutation on Rab38 function 
remained unclear. Although not an invariant residue within the 
Rab family, glycine 19 is conserved in >50% of Rabs and is 
 situated within the generally highly conserved GTP binding 
pocket. The corresponding Rab5 mutant, Rab5A30V, showed in-
creased activity (Li and Liang, 2001). The biochemical proper-
ties of Rab38G19V, however, are not compatible with a functionally 
Figure 6. Distribution of Rab38, Tyrp1, and tyrosinase on 
small cytoplasmic vesicles and tubules. (A) Ultrathin sections 
of MNT-1 cells stably expressing EGFP-Rab38 were labeled 
with antibodies to EGFP or EGFP (10-nm gold) and Tyrp1 (5-nm 
gold), as indicated. EGFP-Rab38 is present on stage IV 
melanosomes and on vesicles and tubules (arrows) near 
melanosomes and the Golgi (GA). (B) BL/6 melanocytes 
 stably expressing EGFP-Rab38 were labeled with antibodies 
to EGFP or EGFP (10-nm gold) and tyrosinase (5-nm gold), as 
indicated. Bars, 200 nm.
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active Rab, and we therefore regard the cht mouse as equivalent 
to a Rab38-null mutant.
In comparison with other mouse pigmentation mutants 
(Li et al., 2004), the cht phenotype is very mild. The similarity 
in coat color, and reduced Tyrp1 levels in cht melanosomes, led 
to the suggestion that the cht mouse may be a phenocopy of the 
brown mouse, with the cht phenotype arising from a defect in 
Tyrp1 traffi cking (Loftus et al., 2002). We now demonstrate that 
pigmentation in cht melanocytes is dependent on Rab32. The 
dramatic loss of pigment in the absence of both Rab38 and 
Rab32 is consistent with a critical role not only in the traffi cking 
of Tyrp1 but also of tyrosinase, the key enzyme in melanin syn-
thesis, which requires the melanosomal environment for cata-
lytic activity (Watabe et al., 2004; Hearing, 2005). On the basis 
of these observations, we would predict a Rab38/Rab32 double-
knockout mouse to show severe hypopigmentation. Compensa-
tion by Rab32 may also explain why mutations in Rab38 have 
not been identifi ed in human patients with oculocutaneous 
 albinism (Suzuki et al., 2003). However, the presence of a detect-
able coat color phenotype in the cht mouse may indicate subtle 
functional differences between the two Rab proteins, possibly 
accounting for the differential expression patterns observed in 
some specialized cell types.
Functional redundancy between mammalian Rab38 
and Rab32 is consistent with the presence of only a single 
 homologue in other species, such as Rab-RP1 in Drosophila 
melanogaster (Fujikawa et al., 2002) or Glo-1 in Caenorhabditis 
elegans (Hermann et al., 2005). Rab-RP1 is mutated in lightoid, 
a D. melanogaster eye color phenotype exhibiting defects in 
pigment granule synthesis (Ma et al., 2004), and C. elegans 
Glo-1 mutants lack lysosome-like gut granules (Hermann et al., 
2005). These observations suggest an evolutionarily conserved 
role for the Rab38/Rab32-related subgroup of Rab proteins 
in the biogenesis of specialized lysosome-related organelles 
(LROs) such as gut granules in C. elegans, eye pigment gran-
ules in D. melanogaster, and mammalian melanosomes.
Defi ciencies in the biogenesis of LROs are also character-
istic of HPS and the mouse models for HPS, with melanocytes 
Figure 7. Loss of mature melanosomes but not stage II organelles in 
Rab38/Rab32-deﬁ cient cells. (A) Cht melanocytes subjected to two rounds 
of transfection with either control or Rab32-speciﬁ c siRNA oligos were 
ﬁ xed, permeabilized, and labeled for Pmel17 with antibody HMB45. 
Note the reduction in pigmented structures in the corresponding brightﬁ eld 
images of Rab32 siRNA–treated cells. (B) Cht cells transfected with control 
siRNA were processed for conventional EM. Melanosomes at different 
stages of maturation are indicated. (C) Cht cells transfected with Rab32-
speciﬁ c siRNA were analyzed as in B. The inset shows immunogold labe-
ling for Pmel17 on stage II melanosomes in cht cells treated with 
Rab32-speciﬁ c siRNA and processed for immuno-EM. N, nucleus; GA, 
Golgi. Bars: (B and C) 500 nm; (inset) 200 nm.
Figure 8. Tyrosinase and Tyrp1 trafﬁ cking to the melanosome is blocked 
in Rab38/Rab32-deﬁ cient cells. Cht melanocytes transfected with either 
control or Rab32-speciﬁ c siRNA oligos as in Fig. 7 were ﬁ xed, permeabi-
lized, and immunolabeled for Tyrp1 and tyrosinase, as indicated. The cor-
responding brightﬁ eld images are shown in the top panels.
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and platelets most severely affected. The corresponding  proteins 
(AP-3, Vps33, and the BLOC subunits), however, are expressed 
ubiquitously, suggesting more general roles in the biogenesis 
of lysosomes (Li et al., 2004; Pietro and Dell’Angelica, 2005). 
In contrast, Rab38 and Rab32 (Jager et al., 2000; Osanai et al., 
2001; Cohen-Solal et al., 2003) were restricted to cell types 
characterized by the presence of LROs, a morphologically 
and functionally diverse group of organelles that includes me-
lanosomes, platelet-dense granules, mast cell granules, lamellar 
bodies of lung epithelial cells, lytic granules of cytotoxic 
T- lymphocytes, and MHC class II compartments of antigen-
 presenting cells (Marks and Seabra, 2001; Stinchcombe et al., 
2004). This further supports a highly specialized role for Rab38 
and Rab32 in LRO function.
Recent studies investigating the intracellular traffi cking of 
melanosomal integral membrane proteins like Pmel17, tyrosi-
nase, and Tyrp1 have revealed much about the formation of me-
lanosomes and the complex sorting pathways involved (Raposo 
and Marks, 2002; Theos et al., 2005a,b; Valencia et al., 2006). 
Premelanosomes appear to be largely derived from endosomal 
precursors, which progress to stage II organelles through the 
Pmel17-dependent formation of lumenal striations. These pro-
vide the fi brillar matrix for the subsequent deposition of mela-
nin, initiated by the delivery of melanogenic enzymes, i.e., 
tyrosinase and tyrosinase-related proteins. The differential en-
richment for Pmel17 in early-stage organelles and tyrosinase 
and Tyrp1 in later-stage pigmented structures provides evidence 
for the existence of distinct sorting pathways to premelano-
somes and to more mature organelles (Raposo et al., 2001). Our 
results suggest that Rab38 and Rab32 are not required for the 
formation of early-stage melanosomes. Traffi cking of tyrosi-
nase and Tyrp1 to these organelles, on the other hand, is depen-
dent on Rab38 or Rab32.
 The subcellular localization of these Rab proteins argues 
for their recruitment to post-TGN transport vesicles and a role 
in regulating the subsequent delivery of such vesicles to matur-
ing melanosomes. Given the loss of tyrosinase in the absence of 
Rab38 and Rab32, this may represent a tissue-specifi c traffi ck-
ing route critical for diverting proteins destined for LROs away 
from the degradative pathway to lysosomes. The TGN localiza-
tion of tyrosinase in Rab38/Rab32-defi cient cells is consistent 
with the recruitment of these Rabs to carrier vesicles derived 
Figure 9. Localization of tyrosinase to the 
TGN in control and Rab38/Rab32-deﬁ cient 
cells. Control or Rab32 (32-2) siRNA–treated 
cht cells were either ﬁ xed under steady-state 
conditions (top) or were incubated with cy-
cloheximide for 3 h before ﬁ xation (bottom; 
+ CHX). Cells were permeabilized and double 
labeled for tyrosinase (red) and TGN38 
(green), as indicated. Colocalization is shown 
as yellow in the merged images. The outline 
of depigmented Rab32 knockdown cells is 
 depicted in the brightﬁ eld images. For com-
parison of tyrosinase levels between panels 
marked with asterisks, images of tyrosinase 
 labeling were acquired using the same mi-
croscope settings; for analysis of colocaliza-
tion with TGN38 in images showing higher 
magniﬁ cations, signal intensities were adjusted 
independently.
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 directly from the TGN. Melanosomal targeting of tyrosinase 
is thought to involve transit through an early endosomal com-
partment (Theos et al., 2005a), which may implicate Rab38/
Rab32 in TGN to endosome traffi cking. Alternatively, tyrosinase 
may traverse the endosome normally in the absence of Rab38 
and Rab32, but may require their subsequent recruitment to 
 endosome-derived transport vesicles. The latter scenario is 
 supported by the continued presence of Rab38 on or in close 
 proximity to mature melanosomes. A detailed analysis of the 
different subpopulations making up the endosomal system should 
prove informative with regard to pinpointing the precise site of 
action of Rab38 and Rab32.
Morphological studies of melanosomes in a range of HPS 
mutants documented disruption of organelle maturation at dis-
tinct stages in different mutants (Nguyen et al., 2002; Nguyen 
and Wei, 2004; Wei, 2006). The molecular mechanisms and 
sites of action of most of the corresponding proteins, in par-
ticular the BLOC components, are still unknown. However, aber-
rant localization of tyrosinase and Tyrp1 is seen in many forms 
of HPS (Gwynn et al., 2004; Richmond et al., 2005). A more 
detailed comparison of melanosomal protein traffi cking in the 
different mutants should shed light on the potential interplay 
between Rab38/Rab32 and other HPS proteins during melano-
some biogenesis.
D. melanogaster lightoid (Rab38/Rab32 homologue) and 
ruby or garnet (AP-3) double mutants show considerably re-
duced eye pigmentation compared with the corresponding 
 single mutants, indicating that lightoid may function in an 
AP-3–independent pathway (Ma et al., 2004). The association 
of Rab38 with Tyrp1 traffi cking (Loftus et al., 2002) and the 
mistargeting of tyrosinase but not Tyrp1 observed in melano-
cytes lacking AP-3 (Huizing et al., 2001) raised the possibility 
that tyrosinase may traffi c via an AP-3–dependent pathway, 
whereas Tyrp1 followed a separate Rab38-dependent route. Our 
results, however, demonstrate a role for Rab38/Rab32 in tyrosi-
nase traffi cking as well. The lack of colocalization between 
Rab38/Rab32 and AP-3 (unpublished data) is consistent with 
the regulation of distinct steps. The plasticity of the sorting 
pathways involved, though (Theos et al., 2005a), could certainly 
result in additive effects upon removal of two components that 
normally act sequentially within the same pathway. Melanosome 
targeting of tyrosinase was more severely impaired than that of 
Tyrp1 upon loss of Rab38/Rab32, possibly indicating that the 
latter can access alternative pathways more effi ciently. For a 
better understanding of Rab38/Rab32 function and the traffi ck-
ing pathways regulated by this subfamily of Rab proteins in me-
lanocytes and other cell types, the identifi cation of interacting 
partners for Rab38 and Rab32 will be of great interest.
Materials and methods
Mice, melanocytes, and cell culture
C57BL/6J-Rab38cht (+/cht) mice were obtained from The Jackson Labora-
tory and were maintained and propagated under UK project licenses 
70/5071 and 70/6210 at the Central Biomedical Services of Imperial 
College London. Primary mouse melanocytes were derived as described 
previously (Hume et al., 2002) and were maintained in RPMI-1640 supple-
mented with 5% FCS, 200 nM phorbol 12-myristate 13-acetate, 200 pM 
cholera toxin, 100 U/ml penicillin G, and 100 U/ml streptomycin at 37°C 
with 10% CO2. The immortal melanocyte cell line melan-Ink4a was derived 
from a/a C57BL/6J mice homozygous for an Ink4a-Arf exon 2 deletion 
(Sviderskaya et al., 2002). Eight independent melan-cht lines  (melan-cht-
1–8) were generated by crossing C57BL/6J-Rab38cht/Rab38cht mice with 
Ink4a-Arf–null mice (to circumvent cell senescence). Melanocyte cultures 
were prepared from individual F2 neonatal mice homozygous for both 
 mutations (provided by L. Lamoreux, Texas A & M University, College Station, 
TX) as described previously (Sviderskaya et al., 2002). Cells were main-
tained in RPMI-1640 supplemented with 10% FCS, 200 nM phorbol 12-
myristate 13-acetate, and 200 pM cholera toxin at 37°C with 10% CO2. 
MNT-1 human melanoma cells were maintained in DME supplemented 
with 10% AIM-V medium, 20% FCS, nonessential amino acids, and 
sodium pyruvate.
Tissue and cell preparations and subcellular fractionation
Mouse tissues were collected from C57BL/6J mice perfused with PBS and 
were homogenized in 3 volumes of 50 mM Hepes, pH 7.2, 10 mM NaCl, 
1 mM dithiothreitol, and protease inhibitor cocktail (Roche). Homogenates 
were centrifuged at 1,000 g for 10 min at 4°C to sediment unbroken cells 
and nuclei. Cultured cells were pelleted and disrupted by sonication in the 
aforementioned buffer. Protein concentrations of postnuclear supernatants 
or whole cell lysates were determined using the Bio-Rad protein assay (Bio-
Rad Laboratories). For subcellular fractionation, cells were disrupted as 
above. Membranes were pelleted by centrifugation at 100,000 g for 1 h 
at 4°C. Alternatively, Triton X-114 (Calbiochem) was added to 1%, sam-
ples were incubated on ice for 10 min, followed by 5 min at 37°C, and 
centrifuged at 16,000 g for 3 min at room temperature. Aqueous and de-
tergent phases were recovered, and the detergent phase was reextracted 
once with buffer. All fractions were adjusted to the same volume, and equal 
volumes were analyzed by SDS-PAGE and immunoblotting.
Figure 10. Expression of exogenous Rab38 
rescues tyrosinase trafﬁ cking in Rab38/Rab32-
deﬁ cient cells. (A) Cht melanocytes were sub-
jected to two rounds of transfection with 
Rab32-speciﬁ c siRNA oligos. On day 6 after 
the initial transfection, cells were transduced 
with lentivirus expressing either EGFP or EGFP-
Rab38, as indicated. 4 d later, cells were ﬁ xed, 
permeabilized, and labeled for tyrosinase 
(red). The corresponding brightﬁ eld images 
and EGFP ﬂ uorescence (green) are also shown. 
(B) EGFP (E) or EGFP-Rab38 (E-38) positive 
cells were scored as either pigmented or depig-
mented, and tyrosinase was categorized as 
 either conﬁ ned to the perinuclear region (TGN 
only) or present in vesicular structures at the 
cell periphery (peripheral). Numbers of cells in 
each category are plotted as a percentage of 
the total number of cells counted (n = 197 cells 
for EGFP; n = 126 cells for EGFP-Rab38).
 o
n
 N
ovem
ber 27, 2014
jcb.rupress.org
D
ow
nloaded from
 
Published October 16, 2006
JCB • VOLUME 175 • NUMBER 2 • 2006 280
Antibodies
To generate polyclonal antibodies to Rab38 and Rab32, the C-terminal 
hypervariable regions of rat Rab38 (residues 162–211) or mouse Rab32 
(residues 175–223) were fused to GST and puriﬁ ed on glutathione–
 Sepharose beads as previously described (Hume et al., 2002). Sera from 
rabbits immunized with these fusion proteins were preabsorbed against 
GST and afﬁ nity puriﬁ ed using the same antigens immobilized on Amino-
Link Coupling Gel (Pierce Chemical Co.) as described previously (Seabra 
et al., 1995). Anti-Rab27a monoclonal antibody 4B12 was described 
 previously (Hume et al., 2001). Rabbit polyclonal anti-tyrosinase PEP7 (IF, 
1:150) was a generous gift from V. Hearing (National Institutes of Health, 
Bethesda, MD). Other antibodies were as follows: rabbit anti-tyrosinase 
(EM; provided by A. Theos and M. Marks, University of Pennsylvania, Phil-
adelphia, PA; Theos et al., 2005a), mouse anti-Tyrp1 TA99 (IF, 1:200 [ID 
Labs]; EM [American Type Culture Collection]), mouse anti-Pmel17 HMB45 
(IF, 1:50 [DakoCytomation]; EM [Labvision]), sheep anti-TGN38 (1:100; 
Serotec), rabbit anti-EGFP (EM; Invitrogen), mouse anti-EGFP (immunoblot; 
1:1,000; Roche), mouse anti–α tubulin and mouse anti–γ tubulin (1:1,000; 
Sigma-Aldrich).
Immunoblotting
Samples were fractionated on 13% SDS-PAGE gels and transferred to poly-
vinylidene diﬂ uoride membrane (Millipore). Membranes were blocked in 
PBS/0.1% Tween-20 (PBS/T) with 4% nonfat dried milk, incubated with 
primary antibody in PBS/T, washed four times in blocking solution, and 
 incubated with horseradish peroxidase–conjugated secondary antibody 
(anti–rabbit or anti–mouse; 1:5,000; DakoCytomation) followed by wash-
ing in PBS/T. Bound antibody was detected using the ECL Plus Western 
blotting detection system (GE Healthcare).
Plasmid constructs
pEGFP-Rab27a, -Rab38, and -Rab32 were generated by subcloning cDNA 
for rat Rab27a, rat Rab38, or human Rab32 into pEGFP (CLONTECH Lab-
oratories, Inc.), using standard cloning techniques. pEGFP-Rab38G19V was 
generated from pEGFP-Rab38 using the QuikChange site-directed muta-
genesis system (Stratagene) to introduce a single nucleotide substitution in 
codon 19 (GGT to GTT). For mRFP-Rab38, Rab38 was ampliﬁ ed from 
pEGFP-Rab38 by PCR using Pfu polymerase (Stratagene) and was sub-
cloned into pRFP-C (monomeric red ﬂ uorescent protein; a gift from R. Tsien, 
University of California, San Diego, La Jolla, CA).
Transfection of cells with plasmids and oligonucleotides
For the introduction of plasmid constructs, cells were transfected with 
 Fugene 6 (Roche) according to the manufacturer’s recommendations. Per 
16-mm well, 0.3 μg DNA and 1 μl transfection reagent were used. Cells were 
analyzed after 48 h. For siRNA oligonucleotides, mouse melanocytes were 
transfected with Oligofectamine (Invitrogen). Per 16-mm well, 0.625 μl 
of reagent was used, and the ﬁ nal concentration of siRNA oligos was 
100 nM. For most experiments shown, cells were subjected to two rounds 
of transfection on days 0 and 5, were passaged as required, and were ana-
lyzed on day 10 or 11. siRNAs were purchased from Dharmacon. Oligo 
32-1 corresponded to nucleotides 261–280 and oligo 32-2 to nucleotides 
602–621 of mouse Rab32. As control, a pool of four nontargeting control 
siRNAs (Dharmacon) was used.
Lentivirus production and infection of melanocytes
The lentivirus vector pHR′SIN-cPPT-SEW (a gift from A. Thrasher, Institute 
of Child Health, London, UK) expresses the EGFP gene under the control 
of the spleen focus forming virus U3 promoter/enhancer and carries a 
modiﬁ ed Woodchuck posttranscriptional regulatory element to improve 
 virus titre, and the central polypurine tract sequence of HIV-1 to aid nuclear 
entry (Demaison et al., 2002). EGFP-Rab38 was ampliﬁ ed from pEGFP-
Rab38 by PCR using Pfu polymerase and was subcloned into this plasmid 
using standard techniques. Lentivirus particles were produced and titred 
as previously described (Waddington et al., 2004). Cells were plated in 
RPMI-1640 with 5% FCS (5 × 104 cells per well) and were infected with 
virus at an approximate MOI of 50 for MNT-1 cells and MOI of 100 for 
mouse melanocytes.
Melanin assay
Cells were disrupted by sonication in 50 mM Tris-HCl, pH 7.4, 2 mM 
EDTA, 150 mM NaCl, 1 mM dithiothreitol, and protease inhibitors.  Pigment 
was pelleted at 20,000 g for 15 min at 4°C, rinsed once in ethanol/ether 
(1:1), and dissolved in 2 M NaOH/20% dimethylsulfoxide at 60°C. 
 Melanin content was measured as optical density at 492 nm.
IF microscopy
Cells were grown on glass coverslips (coated with polylysine for MNT-1 
cells) and transfected with plasmid constructs where indicated. For inhi-
bition of protein synthesis, cycloheximide was added to the growth me-
dium to 100 μg/ml, and cells were incubated for a further 3 h. Cells on 
coverslips were rinsed in PBS, ﬁ xed with 3% PFA in PBS for 30 min, 
rinsed again, and permeabilized with 0.05% saponin in PBS. Cover-
slips were blocked for 30 min, incubated with primary antibodies for 
1.5 h, washed four times and incubated with Alexa 488– or Alexa 
568–conjugated anti–mouse, anti–rabbit or anti–sheep secondary anti-
bodies (1:200; Invitrogen), and washed again. All incubations and 
wash steps were in PBS/BSA/0.01% saponin. Coverslips were mounted 
in Mowiol (Calbiochem) mounting medium and viewed on a microscope 
(DM-IRBE; Leica) with a PL Fluotar 40× 1.0 oil objective. Images were 
acquired using a confocal system (TCS NT; Leica) and processed with 
Photoshop (Adobe).
EM
For conventional EM, cells grown on coverslips were ﬁ xed with 2.5% glu-
taraldehyde in 0.1 M cacodylate buffer for 24 h. After several washes with 
0.1 M cacodylate buffer, the cells were postﬁ xed with 2% OsO4, dehy-
drated in ethanol, and embedded in Epon while on the coverslips. Ultrathin 
sections were prepared and counterstained with uranyl acetate and lead 
citrate before observation. For immunogold labeling, cells were ﬁ xed with 
2% PFA or with a mixture of 2% PFA and 0.2% glutaraldehyde in 0.1 M 
phosphate buffer, pH 7.4. Cells were processed for ultracryomicrotomy as 
described previously (Raposo et al., 1997). Ultrathin sections were pre-
pared with an Ultracut FCS ultracryomicrotome (Leica), and single- or 
 double-immunogold labeled with antibodies and protein A coupled to 5 or 
10-nm gold, as indicated in the ﬁ gure legends. Sections were observed 
and photographed under an electron microscope (Philips CM120; FEI 
Company). Digital acquisitions were made with a numeric camera (Keen 
View; Soft Imaging System).
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